Several experimental studies have indicated that SP‐D levels in broncho‐alveolar lavage fluid (BAL) decrease and serum levels increase in patients suffering from asthma possibly due to both induced SP‐D synthesis and decreased air–blood barrier integrity.10, 11, 12, 13. The gene discussed is SFTPD; the disease is asthma.